G01N 2800/224
Haemostasis or coagulation
G01N2800/224 (Haemostasis or coagulation) appears on 119 US grants and 186 published applications in this corpus.
Search patents in G01N- Granted patents
- 119
- Published applications
- 186
- Assignees
- 119
- Inventors
- 348
- Latest grant
- 23 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 3 |
| 2003 | 2 | 2 |
| 2004 | 1 | 1 |
| 2005 | 0 | 2 |
| 2006 | 0 | 5 |
| 2007 | 3 | 5 |
| 2008 | 1 | 2 |
| 2009 | 1 | 8 |
| 2010 | 3 | 11 |
| 2011 | 3 | 2 |
| 2012 | 3 | 7 |
| 2013 | 2 | 11 |
| 2014 | 7 | 5 |
| 2015 | 8 | 14 |
| 2016 | 4 | 16 |
| 2017 | 9 | 14 |
| 2018 | 12 | 12 |
| 2019 | 9 | 10 |
| 2020 | 4 | 5 |
| 2021 | 11 | 6 |
| 2022 | 8 | 17 |
| 2023 | 8 | 8 |
| 2024 | 9 | 11 |
| 2025 | 7 | 8 |
| 2026 | 3 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Cartridge device for a measuring system for measuring viscoelastic characteristics of a sample liquid, a corresponding measuring system, and a corresponding method23 Jun 2026US 12,663,429 B2C A Casyso GmbH
- Apparatus and method to determine stroke subtype21 Apr 2026US 12,607,641 B2Haemonetics Corporation
- Method for measuring platelet activation based on soluble CLEC-2 and platelet count31 Mar 2026US 12,590,978 B2PHC Corporation
- Assays for determining plasma kallikrein system biomarkers14 Oct 2025US 12,442,824 B2Takeda Pharmaceutical Company Limited
- Monoclonal antibody against D-dimer and diagnosis agent for detecting D-dimer, crosslinked fibrin and its derivatives containing D-dimer by using the antibody30 Sep 2025US 12,429,488 B2Princeton Biomeditech Corporation
- Reagent and method for diagnosing thrombotic events22 Jan 2026US 2026/0023088 A1Biokit Research & Development S.L.U.
- Compositions for detection of hyperfibrinolysis and fibrinolytic shutdown and uses thereof27 Nov 2025US 2025/0362314 A1Instrumentation Laboratory Company
- Sample measurement apparatus and sample measurement method14 Aug 2025US 2025/0258186 A1Sysmex Corporation
- Coagulation time extension factor estimation method3 Jul 2025US 2025/0216405 A1Sekisui Medical Co., Ltd.
- Metabolite biomarkers for diseases associated with the contact activation system19 Jun 2025US 2025/0199014 A1Takeda Pharmaceutical Company Limited
Most cited
By later US patents
- Device, systems and methods for evaluation of hemostasis97US 9,272,280 B2HemoSonics LLC · 2016
- Devices, systems and methods for evaluation of hemostasis74US 9,977,039 B2HemoSonics LLC · 2018
- Devices, systems and methods for evaluation of hemostasis73US 9,410,971 B2HemoSonics LLC · 2016
- Devices, systems and methods for evaluation of hemostasis69US 10,031,144 B2HemoSonics LLC · 2018
- Method for monitoring coagulability and hypercoagulable states55US 7,169,573 B2Oklahoma Medical Research Foundation · 2007